Selinexor
IIT2022053
Phase 2 small_molecule terminated
Quick answer
Selinexor for Acute Myeloid Leukemia, Adult is a Phase 2 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hospital Authority, Hong Kong
- Indication
- Acute Myeloid Leukemia, Adult
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated